Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 795 results for "gsk consumer healthcare"

Buy GSK Consumer; target of Rs 5815: Firstcall Research

Brokerage house Firstcall Research is bullish on GlaxoSmithKline Consumer Healthcare and has recommended buy rating on the stock with a target price of Rs 5815 in its research report dated September 25, 2014. Money Control, 1 day ago

37 images for gsk consumer healthcare

Fidelity Brokerage Services LLC, 3 weeks ago, 1 month ago
Yahoo! News Australia, 3 weeks ago, 1 month ago
Talking Retail, 1 month ago
International Business Times UK, 3 weeks ago
Business Insider, 3 weeks ago
Reuters, 3 weeks ago
Reuters, 3 weeks ago
Yahoo! News, 3 weeks ago
Reuters UK

Interview: Optimal oral health for the world's population

FDI President Dr Tin Chun Wong (left) with David A. Ross, Global Head of Sales Force Effectiveness at GSK Consumer Healthcare. (Photograph: Daniel Zimmermann, DTI) As a first, GlaxoSmithKline recently announced that it has developed sales ...
 Dental Tribune2 weeks ago After China, GSK faces pressure for change  Qatar Peninsula1 week ago After China, Glaxo faces pressure for change  Gulf Times1 week ago After China, GlaxoSmithKline faces pressure for change  Livemint.com1 week ago
Talking Retail

Snapshots of GlaxoSmithKline's Consumer Healthcare Division and Horlicks Sales

Analyst Insight by Hope Lee - Senior Beverages Analsyt The bribery case in China and disappointing second-quarter results have put GlaxoSmithKline (GSK) in the headlines again. The pharmaceutical giant was initially reported to be looking to spin ...
 Euromonitor International3 weeks ago GSK appoints new sales director  Talking Retail1 month ago GSK-CH relaunches Horlicks  Money Control1 month ago GSK India relaunches Horlicks  Hindu Business Line1 month ago

GSK Consumer Healthcare: Updates on outcome of AGM

GlaxoSmithkline Consumer Healthcare Ltd has submitted to BSE a copy of the minutes of the 55th Annual General Meeting (AGM) of the Company held on August 07, 2014.
 Money Control4 weeks ago

GSK Consumer Healthcare: Outcome of AGM

GlaxoSmithkline Consumer Healthcare Ltd has informed BSE that the 55th Annual General Meeting (AGM) of the Company was held on August 07, 2014.
 Money Control1 month ago GSK Consumer Healthcare's AGM on August 07, 2014  Money Control2 months ago


GlaxoSmithKline Consumer Healthcare reported CVS is banning the sale of cigarettes and other harmful tobacco products. According to a company release, GSK encourages all smokers who are emboldened by CVS' decision to look into its products ...
 4 Traders3 weeks ago GSKCH evaluating Physiogel, NiQuitin products for India  Financial Chronicle1 month ago

GSK Consumer: Muted volumes, higher costs impact Q1 show

The impact of weakening domestic consumer demand also reflected on the June quarter results of GlaxoSmithKline Consumer Healthcare (GSK Consumer), which missed street expectations on many fronts.While subdued volume growth (lowest over past three ...
 Business Standard1 month ago
Yahoo! UK and Ireland

Meet The 2 Best Healthcare Stocks Your Money Can Buy: AstraZeneca plc & GlaxoSmithKline plc

2014 has been a very different experience for investors in AstraZeneca (LSE:AZN) (NYSE: AZN.US) and GlaxoSmithKline (LSE:GSK) (NYSE: GSK.US). That's because, while shares in the former have risen by a stunning 26%, the latter has seen its share ...
 Interactive Investor3 weeks ago

GlaxoSmithkline Consumer Healthcare drops after Q1 results

GlaxoSmithkline Consumer Healthcare lost 0.32% to Rs 4,858 at 10:20 IST on BSE after net profit net profit rose 8.46% to Rs 130.12 crore on 8.92% growth in total income to Rs 1011.73 crore in Q1 June 2014 over Q1 June 2013. The Q1 result was ...
 India Infoline1 month ago

GSK receives FDA approval of an additional Promacta®; Jardiance Tablets For Adult Type 2 Diabetes available In U.S. Pharmacies

Below is a look at some of the headlines for companies that made news in the healthcare sector on August 26, 2014. GlaxoSmithKline plc (LSE/NYSE: GSK) announced today that the U.S. Food and Drug Administration (FDA) has approved a supplemental ...
 BioMedReports1 month ago GSK receives FDA approval for allergy relief medication  Individual.com1 month ago FDA approves Flonase allergy relief for sale over-the-counter in the United States  PressReleasePoint1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less